Background glaucoma Shape Background glaucoma Shape Background glaucoma Shape
Grants > Interleukin-10 As a Neuroprotective Factor in Glaucoma Updated On: Jul 10, 2025
National Glaucoma Research Grant

Interleukin-10 As a Neuroprotective Factor in Glaucoma

Understanding What Causes Glaucoma
Tatjana Jakobs

Principal Investigator

Tatjana Jakobs, MD

The Schepens Eye Research Institute, Mass. Eye and Ear

Boston, MA, USA

About the Research Project

Program

National Glaucoma Research

Award Type

Standard

Award Amount

$182,000

Active Dates

July 01, 2025 - June 30, 2027

Grant ID

G2025008S

Goals

The goal is to investigate the role of immune cells (microglia) in glaucoma and test factors secreted by microglia for neuroprotective activity in glaucoma.

Summary

Visual impairment in glaucoma is caused by the degeneration and eventual death of retinal ganglion cells through mechanisms that are not fully understood. Retinal microglia can play neuroprotective and neurotoxic roles in glaucoma. We identified IL10 as a candidate for a microglia-derived factor that may selectively boost the neuroprotective effects.

Unique and Innovative

We identified IL10 as a microglia-derived factor with potential neuroprotective effects on retinal ganglion cells. We will test this with assays of visual function and microscopic analysis of ganglion cell morphology.

Foreseeable Benefits

Ultimately, we hope to develop a combination of several factors that can be administered to prevent ganglion cell loss in glaucoma. We also hope to gain insight into the function of immune cells in neurodegenerative diseases such as glaucoma or Alzheimer’s disease.